[Skip to Navigation]
Sign In
Views 124
Citations 0
Comment & Response
November 18, 2020

The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes—Reply

Author Affiliations
  • 1The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil
  • 2Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada
  • 3Department of Health Sciences, University of Leicester College of Medicine, Leicester, England
  • 4Diabetes Complications Research Center, UCD Conway Institute, University College Dublin School of Medicine, Dublin, Ireland
JAMA Surg. 2021;156(2):206-207. doi:10.1001/jamasurg.2020.5192

In Reply The Microvascular Outcomes After Metabolic Surgery (MOMS) study demonstrated that Roux-en-Y gastric bypass (RYGB) can be used to place early stages of chronic kidney disease (CKD) in patients with type 2 diabetes into remission.1 Patoulias et al suggested that remission of albuminuria was enhanced by RYGB because more of these patients at baseline received glucagon-like peptide-1 receptor agonist (GLP-1RA). A subanalysis of patients undergoing RYGB according to presurgery treatment with a GLP-1RA found that the treatment did not predict albuminuria response. It should be remembered that GLP-1RA were stopped immediately after RYGB, although metformin, angiotensin-converting enzyme inhibitors, and statins were continued where possible.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words